CIBC World Market
PRME icon

CIBC World Market’s Prime Medicine PRME Stock Holding History

CIBC World Market’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.9K Buy
+18,662
New +$62K ﹤0.01% 1522
2025
Q3 		– Sell
-14,326
Closed -$35.4K – 1467
2025
Q2 		$35.4K Sell
14,326
-2,689
-16% -$4.14K ﹤0.01% 1339
2025
Q1 		$33.9K Sell
17,015
-2,008
-11% -$5.12K ﹤0.01% 1337
2024
Q4 		$56K Buy
19,023
+8,801
+86% +$30.9K ﹤0.01% 1332
2024
Q3 		$40K Sell
10,222
-1,113
-10% -$5.16K ﹤0.01% 1282
2024
Q2 		$58K Sell
11,335
-712
-6% -$4.32K ﹤0.01% 1233
2024
Q1 		$84K Sell
12,047
-214
-2% -$1.62K ﹤0.01% 1256
2023
Q4 		$109K Buy
+12,261
New +$94.5K ﹤0.01% 1200

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

CIBC World Market's PRME Position: Q2 2026 in Review

CIBC World Market opened a new position in Prime Medicine (PRME) in Q2 2026: 18,662 shares worth $68.9K. The stake represents ﹤0.01% of the portfolio and ranks #1522 among its holdings. This is a return to the name: CIBC World Market previously reported a position in PRME as recently as Q2 2025.

CIBC World Market first reported a position in PRME in Q4 2023 and has held it in 8 quarters since. The position peaked at $109K in Q4 2023. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • CIBC World Market held 18,662 shares of Prime Medicine worth $68.9K as of Q2 2026.
  • Prime Medicine was a new CIBC World Market position in Q2 2026.
  • Prime Medicine made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1522 holding.
  • CIBC World Market first reported a position in Prime Medicine in Q4 2023 and has held it in 8 quarters since.
  • CIBC World Market's Prime Medicine position peaked at $109K in Q4 2023.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.